Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Different Doses of Losartan Potassium (MK0954-011) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the efficacy and safety of different doses of losartan potassium (MK0954-011) in hypertension, with results posted for a completed tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Cozaar (losartan)
• Losartan Potassium (Losartan potassium)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2009-06-10